Care for Chronic Obtrusive Pulmonary Disease
 
 

  • To be told that the study involves research.
  • To be told the purpose of the clinical trial.
  • To be told any reasonably foreseeable risks, side effects or discomforts that might be expected.
  • To be told of any benefits to the participant or to others that can be reasonably expected.
  • To be told what procedures will be administered and whether any of them are experimental.
  • To be told of appropriate alternative drugs, treatments, or procedures that might be advantageous to the participant.
  • To be allowed to ask any questions about the trial before giving consent and at any time during the course of the study.
  • To be told who they can contact with questions about the study, their rights as a participant and who to contact in the case of a research-related injury.
  • To be allowed ample time, without pressure, to decide whether to consent or not to consent to participate.
  • To refuse to participate, for any reason, before and after the trial has started.
  • To be informed that if they refuse to participate or decide to stop participating, they will not suffer any penalty or loss of benefits.
  • To receive a signed and dated copy of the informed consent form.

 

 

© Copyright 2008 Needham and Company; all rights reserved.